brl 44408 has been researched along with kampirone in 1 studies
| Studies (brl 44408) | Trials (brl 44408) | Recent Studies (post-2010) (brl 44408) | Studies (kampirone) | Trials (kampirone) | Recent Studies (post-2010) (kampirone) |
|---|---|---|---|---|---|
| 82 | 0 | 16 | 88 | 13 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lodge, NJ; Myers, RA; Plym, MJ; Signor, LJ | 1 |
1 other study(ies) available for brl 44408 and kampirone
| Article | Year |
|---|---|
1-(2-pyrimidinyl)-piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat.
Topics: Acetic Acid; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Anesthesia; Animals; ATP-Binding Cassette Transporters; Benzhydryl Compounds; Buspirone; Cresols; Cromakalim; Dose-Response Relationship, Drug; Female; Imidazoles; Indoles; Isoindoles; KATP Channels; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Phenylpropanolamine; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Tolterodine Tartrate; Urinary Bladder; Urodynamics; Yohimbine | 2004 |